Regulation - Asia-Pacific, Patents

Filter

Current filters:

Asia-PacificPatents

Popular Filters

Roche sues Biocon and Mylan over Herceptin biosimilar; US puts pressure on India over IP

Roche sues Biocon and Mylan over Herceptin biosimilar; US puts pressure on India over IP

10-02-2014

Swiss pharma major Roche’s Indian subsidiary has sued Bangalore-based Biocon and US generics firm Mylan…

Asia-PacificBioconBiosimilarsCanmabHerceptinHertrazIndiaLegalMylan LaboratoriesOncologyPatentsPharmaceuticalRegulationRoche

Indian pharmaceutical market to reach $56 billion by 2020, says GlobalData

03-10-2013

Driven by the country’s growing economy and population income, the Indian pharmaceutical market will…

Asia-PacificMarkets & MarketingPatentsPharmaceuticalRegulation

Ahead of 2013 federal election, trade group makes plea for fixing Australia's PBS listing system

27-05-2013

Pharma trade group Medicines Australia today (May 27) launched its 2013 Federal Election document, calling…

Asia-PacificHealthcarePatentsPharmaceuticalPoliticsPricingRegulation

US and Indian biotech industry find common ground on key issues

13-09-2012

The third annual BIO India conference kicked off yesterday in Mumbai with significant agreement among…

Asia-PacificBiotechnologyNorth AmericaPatentsRegulationResearch

Australian medicines could lead the way for manufacturing in the "Asian century"

17-06-2012

If supported by good public policy, medicines could play a significant role in ensuring Australia adapts…

Asia-PacificGenericsMarkets & MarketingPatentsRegulation

Back to top